Use of Modified Glucose-Insulin-Potassium Mixture in Cardiosurgical Patients
https://doi.org/10.15360/1813-9779-2006-6-163-166
Abstract
The investigation was undertaken to study the hemodynamic and metabolic effects of modified (with elevated glucose and insulin levels) glucose-insulin-potassium (GIP) mixture in the correction of acute heart failure in cardiosurgical patients. After infusion of the modified GIP mixture (0.9 g of glucose per kg body weight and 3.75 units of insulin per g glucose), in 15 patients (12 males and 3 females) aged 35 to 72 (54±5) years the increase (p<0.05) in cardiac index and stroke volume index was 21% with simultaneous 20 and 17% decreases in pulmonary wedge pressure and mean pulmonary pressure, respectively (p<0.05). The duration of infusion was 5 hours. A steady-state improvement of cardiac pump function and metabolic parameters could reduce the dosage of cardiotonic drugs 12 hours after administration of the modified GIP mixture. During and after administration of the mixture, the blood levels of glucose and potassium were substantially unchanged. In the study group, all the patients survived. The duration of a resuscitative period was 2.4±0.2 days. With the management protocol used, infusion of the modified GIP mixture was favorable to the steady-state improvement of cardiac pump function without carbohydrate and electrolyte homeostatic impairments.
acute heart failure; glucose-insulin-potassium mixture
About the Authors
V. N. PoptsovYe. V. Morozyuk
B. Yu. Bogomolov
References
1. Apstein C. The benefits of glucose-insulin-potassium for acute myocardial infarction. Am. Coll. Cardiol. 2003; 42: 792—795.
2. Diaz R., Paolasso E. C., Piegas L. S. et al. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial. Circulation 1998; 98: 2223—2226.
3. Козлов И. А., Попцов В. Н., Клыпа Т. Ю., Морев Э. К. Выбор варианта анестезии и особенности симпатомиметической терапии при трансплантации сердца после дистанционного забора. Бюл. НЦССХ им. Бакулева А.Н. РАМН. Сердечно-сосудистые заболевания, проблемы трансплантологии 2004; 5 (7): 125—134.
4. Obadia J. F., Girard C., Ferrara R. et al. Long conservation organs in heart transplantation: postoperative results and long-term follow-up in fourteen patients. J. Heart Lung Transplant. 1997; 16: 256—259.
5. Jain U. Myocardial infarction during coronary artery bypass surgery. J. Cardiothorac. Vasc. Anesth. 1992; 6: 612—623.
6. Jaquet L., Noirhomme P., EL Khoury G. et al. Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur. J. Cardiothorac. Surg. 1998; 13: 378—384.
7. Apstein C. S. Glucose-Insulin-Potassium in acute myocardial infarction. Circulation 1997; 96: 1074—1077.
8. Cave A. C., Ingwall J. S., Friedrich J. R. et al. ATP synthesis during lowflow ischemia: influence of increased glycolytic substrate. Circulation 2000; 101 (17): 2090—2096.
9. Fath-Ordoubadi F., Beatt K. J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997; 96: 1152—1156.
10. Bruemmer-Smith S., Avidan M. S., Harris B. et al. Glucose, insulin and potassium protection during cardiac surgery. Br. J. Anaesth. 2002; 88: 489—495.
11. Мещеряков А. В., Лахтер М. А., Козлов И. А. и др. Нарушение метаболизма глюкозы и изменение активности инсулина при операциях на открытом сердце. Анестезиология и реаниматология 1989; 5: 12—17.
12. Broomhead C. J., Colvin M. P. Glucose, insulin and cardiovascular system. Heart 2001; 85: 495—496.
13. Ceremuzynski L., Budaj A., Czepeiel A. et al. Low-dose glucose-insulinpotassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trail. Cardiovasc. Drugs. Therap. 1999; 13 (3): 191—200.
Review
For citations:
Poptsov V.N., Morozyuk Ye.V., Bogomolov B.Yu. Use of Modified Glucose-Insulin-Potassium Mixture in Cardiosurgical Patients. General Reanimatology. 2006;2(6):163-166. (In Russ.) https://doi.org/10.15360/1813-9779-2006-6-163-166